Toxic Shock Syndrome Toxin-1-Induced Death Is Prevented by CTLA4Ig

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 3869-3875

  Saha, Bhaskar ^a   Jaklic, Beth ^a   Harlan, David M ^a   Gray, Gary S ^b   June, Carl H ^a   Abe, Ryo ^a,c,d  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b REPLIGEN CORPORATION   (United States)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; BACTERIAL TOXIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; REGULATORY T LYMPHOCYTE; SECRETION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BACTERIAL TOXINS; ENTEROTOXINS; FEMALE; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT FUSION PROTEINS; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030293507     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Chatila, T., P. Scholl, N. Ramesh, N. Trede, R. Fuleihan, T. Morio, and R. S. Geha. 1992. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin. Chem. Immunol. 55:146.
2. Uchiyama, T., Y. Kamagata, M. Wakai, M. Yoshioka, H. Fujikawa, and H. Igarashi. 1986. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin. Microbiol. Immunol. 30:469.
3. Kotzin, B. L., D. Y. Leung, J. Kappler, and P. Marrack. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54:99.
4. Chatila, T., P. Scholl, F. Spertini, N. Ramesh, N. Trede, R. Fuleihan, and R. S. Geha. 1991. Toxic shock syndrome toxin-1, toxic shock, and the immune system. Curr. Top. Microbiol. Immunol. 174:63.
5. Miethke, T., K. Duschek, C. Wahl, K. Heeg, and H. Wagner. 1993. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur. J. Immunol. 23:1494.
6. Choi, Y., J. A. Lafferty, J. R. Clements, J. K. Todd, E. W. Gelfand, J. Kappler, P. Marrack, and B. L. Kotzin. 1990. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172:981.
7. Norton, S. D., P. M. Schlievert, R. P. Novick, and M. K. Jenkins. 1990. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1. J. Immunol. 144:2089.
8. Fleischer, B., and U. Hartwig. 1992. T-lymphocyte stimulation by microbial superantigens. Chem. Immunol. 55:36.
9. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:1066.
10. Uchiyama, T., T. Tadakuma, K. Imanishi, M. Araake, S. Saito, X. J. Yan, H. Fujikawa, H. Igarashi, and N. Yamaura. 1989. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. J. Immunol. 143:3175.
11. Akatsuka, H., K. Imanishi, K. Inada, H. Yamashita, M. Yoshida, and T. Uchiyama. 1994. Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1. Clin. Exp. Immunol. 96:422.
12. Jupin, C., S. Anderson, C. Damais, J. E. Alouf, and M. Parant. 1988. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J. Exp. Med. 167:752.
13. Galelli, A., S. Anderson, B. Charlot, and J. E. Alouf. 1989. Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1. J. Immunol. 142:2855.
14. Boussiotis, V. A., J. G. Gribben, G. J. Freeman, and L. M. Nadler. 1994. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr. Opin. Immunol. 6:797.
15. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
16. June, C. H., J. A. Ledbetter, P. S. Linsley, and C. B. Thompson. 1990. Role of the CD28 receptor in T-cell activation. Immunol. Today 11:211.
17. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
18. Freeman, G. J., G. S. Gray, C. D. Gimmi, D. B. Lombard, L. J. Zhou, M. White, J. D. Fingeroth, J. G. Gribben, and L. M. Nadler. 1991. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174:625.
19. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
20. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, K. S. Hathcock, G. Laszlo, A. J. McKnight, J. Kim, L. Du, D. B. Lombard, G. S. Gray, L. M. Nadler, and A. M. Sharpe. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907.
21. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76
22. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med 174:561.
23. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
24. Harlan, D. M., H. Hengartner, M. L. Huang, Y. H. Kang, R. Abe, R. W. Moreadith, H. Pircher, G. S. Gray, P. S. Ohashi, G. J. Freeman, L. M. Nadler, C. H. June, and P. Aichele. 1994. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 91:3137.
25. Lin, H., S. F. Bolling, P. S. Linsley, R. Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178:1801.
26. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
27. Harlan, D. M., R. Abe, K. P. Lee, and C. H. June. 1995. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin. Immunol. Immunopathol. 75:99.
28. Damle, N. K., K. Klussman, G. Leytze, and P. S. Linsley. 1993. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7. J. Immunol. 150:726.
29. Mittrucker, H. W., and B. Fleischer. 1992. Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins. Cell Immunol. 139:108.
30. Dohlsten, M., G. Hedlund, P. A. Lando, J. Trowsdale, D. Altmann, M. Patarroyo, H. Fischer, and T. Kalland. 1991. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity. Eur. J. Immunol. 21:131.
31. Chatila, T., N. Wood, J. Parsonnet, and R. S. Geha. 1988. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells. J. Immunol. 140:1250.
32. Rott, O., U. Tontsch, and B. Fleischer. 1993. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens. J. Immunol. 150:87.
33. Muraille, E., G. Dedecker, M. Bakkus, K. Thielemans, J. Urbain, M. Moser, and O. Leo. 1995. Costimulation lowers the threshold for activation of naive T cells by bacterial superantigens. Int. Immunol. 7:295.
34. Muraille, E., T. DeSmedt, K. Thielemans, J. Urbain, M. Moser, and O. Leo. 1995. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Cell. Immunol. 162:315.
35. Muraille, E., T. DeSmedt, J. Urbain, M. Moser, and O. Leo. 1995. B7.2 provides co-stimulatory functions in vivo in response to staphylococcal enterotoxin B. Eur. J. Immunol. 25:2111.
36. Abe, R., J. J. Ryan, and R. J. Hodes. 1987. Clonal analysis of the MIs system: a reappraisal of polymorphism and allelism among Mlsa, Mlsc and Mlsd. J. Exp. Med. 165:1113.
37. + splenic T cells after CD28 receptor ligation. J. Immunol. 154:985.
38. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
39. Lehmann, V., M. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
40. Saha, B., D. Harlan, K. Lee, C. June, and R. Abe. 1996. Protection against lethal toxic shock by targeted disruption of the CD28 gene. J. Exp. Med. 183:2675.
41. Gimmi, C. D., G. J. Freeman, J. G. Gribben, G. Gray, and L. M. Nadler. 1993. Human T-cell clonal anergy is induced by antigen presented in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA 90:6586.
42. Lenschow, D. J., and J. A. Bluestone. 1993. T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 5:747.
43. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
44. Walter, H., S. Schepensn, J. Van Wauwe, and M. de Boer. 1994. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines. Eur. Cytokine Netw. 5:13.
45. Krakauer, T., and J. J. Oppenheim. 1993. IL-1 and tumor necrosis factor-α each up-regulate both the expression of IFN-γ receptors and enhance IFN-γ-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J. Immunol. 150:1205.
46. Lucas, P. J., I. Negishi, K. Kakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
47. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
48. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kranke, and T. W. Mak. 1993. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
49. Pimentel Muinos, F. X., J. Mazana, and M. Fresno. 1994. Regulation of interleukin-2 receptor alpha chain expression and nuclear factor kappa B activation by protein kinase C in T lymphocytes: autocrine role of tumor necrosis factor alpha. J. Biol. Chem. 269:24424.
50. Pimentel Muinos, F. X., M. A. Munoz Fernandez, and M. Fresno. 1994. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:5714.
51. Hakim, F., and R. Cepeda. 1995. Acute graft-versus-host reaction can be aborted by blockade of costimulatory molecules. J. Immunol. 155:1757.
52. Zheng, L., L. Fischer, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:148.
53. Khoury, S., W. Hancock, and H. Weiner. 1996. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin-4, prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
54. + T and NK cells. J. Exp. Med. 180:1937.
55. + T cells secreting Th1 and Th2 cytokines. Immunity 2:271.
56. + suppressor effector T cell clones from cytotoxic T cell clones by cotokine production and CD45 isoforms. J. Immunol. 150:2121.
57. Das, M. P., S. Zamvil, F. Borrielo, H. Weiner, A. Sharpe, and V. Kuchroo. 1996. Reciprocal expression of co-stimulatory molecules, B7.1 and B7.2, on murine T cells following activation. Eur. J. Immunol. 25:207.